#CMS offers flexibility for value-based care models affected by #COVID19, which include extending #NextGen ACO model through 2021. https://t.co/FUUoVHUFvs
England's National Institute of Health and Care Excellence (NICE) rejects Novartis' Aimovig on data 'uncertainty' despite migraine benefits https://t.co/tFxRKbaklu